Home > Income Statement > GENPHARMASEC

GENPHARMASEC
Revenue

    Back to Income Statement
GENPHARMASEC is part of below Screeners ↓
Top Undervalued Small Cap Stocks
AD     Remove this Ad

GENPHARMASEC Last 5 Year Revenue History

[Consolidated]

Mar2025Mar2024Mar2023
Net Sales ₹30 Cr₹26 Cr₹26 Cr

What is the latest Revenue of GENPHARMASEC ?

The latest Revenue ratio of GENPHARMASEC is ₹30 Cr based on Mar2025 Consolidated results.
Year Revenue
Mar2025₹30 Cr
Mar2024₹26 Cr
Mar2023₹26 Cr

How is Revenue of GENPHARMASEC Trending?

Years Revenue % Change
Mar2025 ₹30 Cr
19.16
Mar2024 ₹26 Cr
0.00
Mar2023 ₹26 Cr -

Compare Revenue of peers of GENPHARMASEC

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GENPHARMASEC ₹64.2 Cr NA -12.1% -51.9% Stock Analytics
SUDARSHAN CHEMICAL INDUSTRIES ₹7,226.8 Cr 3% -5.2% -6% Stock Analytics
KIRI INDUSTRIES ₹3,001.7 Cr 9% -12.1% -22.6% Stock Analytics
VIDHI SPECIALTY FOOD INGREDIENTS ₹1,581.5 Cr 2.2% -4.1% -35.3% Stock Analytics
SHREE PUSHKAR CHEMICALS & FERTILISERS ₹1,096.4 Cr -3.1% -5.3% 27.7% Stock Analytics
BODAL CHEMICALS ₹646.3 Cr 8.5% -2% -17.5% Stock Analytics


GENPHARMASEC Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
GENPHARMASEC NA

-12.1%

-51.9%

SENSEX

1.3%

-2.5%

8.5%


You may also like the below Video Courses